These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16681766)

  • 1. The effect of long-term use of progesterone therapy on proliferation and apoptosis in simple endometrial hyperplasia without atypia.
    Bese T; Vural A; Ozturk M; Dagistanli F; Demirkiran F; Tuncdemir M; Arvas M; Sanioglu C; Kosebay D
    Int J Gynecol Cancer; 2006; 16(2):809-13. PubMed ID: 16681766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
    Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
    Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genistein aglycone: a new therapeutic approach to reduce endometrial hyperplasia.
    Bitto A; Granese R; Triolo O; Villari D; Maisano D; Giordano D; Altavilla D; Marini H; Adamo EB; Nicotina PA; D'Anna R; Squadrito F
    Phytomedicine; 2010 Sep; 17(11):844-50. PubMed ID: 20570122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy of micronized progesterone and lynestrenol in treatment of simple endometrial hyperplasia without atypia.
    Tasci Y; Polat OG; Ozdogan S; Karcaaltincaba D; Seckin L; Erkaya S
    Arch Gynecol Obstet; 2014 Jul; 290(1):83-6. PubMed ID: 24488582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative and apoptotic changes in the healthy canine endometrium and in cystic endometrial hyperplasia.
    Reusche N; Beineke A; Urhausen C; Beyerbach M; Schmicke M; Kramer S; Günzel-Apel AR
    Theriogenology; 2018 Jul; 114():14-24. PubMed ID: 29574305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of simple and complex endometrial non-atypical hyperplasia with natural progesterone: response rate to different doses.
    Marra C; Penati C; Ferrari L; Cantù MG; Bargossi L; Fruscio R
    Gynecol Endocrinol; 2014; 30(12):899-901. PubMed ID: 25111756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
    Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
    Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
    Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
    Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia.
    Girbash EF; Sherif HE; Radwan AM; Abdeldayem HM
    Arch Gynecol Obstet; 2023 Sep; 308(3):947-952. PubMed ID: 37010614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing letrozole with medroxyprogesterone acetate (MPA) as hormonal therapy for simple endometrial hyperplasia without atypia in adult and middle-aged women.
    Tabatabaie A; Karimi Zarchi M; Dehghani-Tafti M; Miratashi-Yazdi A; Teimoori S; Dehghani A
    Eur J Gynaecol Oncol; 2013; 34(6):552-5. PubMed ID: 24601050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
    Vereide AB; Kaino T; Sager G; Ørbo A;
    Gynecol Oncol; 2005 Jun; 97(3):740-50. PubMed ID: 15885761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study.
    Emarh M
    Arch Gynecol Obstet; 2015 Dec; 292(6):1339-43. PubMed ID: 26015309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study.
    Grimbizis G; Tsalikis T; Tzioufa V; Kasapis M; Mantalenakis S
    Hum Reprod; 1999 Feb; 14(2):479-84. PubMed ID: 10099998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antiproliferative effects of metformine and progesterone on estrogen-induced endometrial hyperplasia in rats.
    Tas M; Kutuk MS; Serin IS; Ozgun MT; Oner G; Ozturk F
    Gynecol Endocrinol; 2013 Apr; 29(4):311-4. PubMed ID: 23305503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
    Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
    Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy of Dienogest in the Treatment of Simple Endometrial Hyperplasia without Atypia.
    Uysal G; Acmaz G; Madendag Y; Cagli F; Akkaya H; Madendag I; Karakilic EU
    Gynecol Obstet Invest; 2018; 83(2):151-155. PubMed ID: 28715800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of three progestins in the treatment of simple endometrial hyperplasia without atypia.
    Ozdegirmenci O; Kayikcioglu F; Bozkurt U; Akgul MA; Haberal A
    Gynecol Obstet Invest; 2011; 72(1):10-4. PubMed ID: 21266792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma.
    Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
    J Med Assoc Thai; 2008 Aug; 91(8):1161-5. PubMed ID: 18788685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.